Immune
Response
Research
Immunology Investigating how the human immune system responds to infectious diseases, vaccines, and emerging pathogens — providing insights essential for developing diagnostics, therapeutics, and vaccines suited to African populations.
What the Team
Investigates
Characterising innate and adaptive immune responses to infectious diseases to identify correlates of protection and vulnerability in African populations.
Evaluating antibody responses, T cell activation, and immune memory following vaccination to inform vaccine development and deployment strategies.
Investigating inflammatory pathways and cytokine profiles in severe infectious disease to identify targets for therapeutic intervention.
Using immunological insights to develop and validate rapid diagnostic tools and serological assays suited to African health systems.
Examining how host genetic variation influences immune responses to pathogens and vaccines in diverse African populations.
Driving African-led immunology research and building local capacity to develop therapeutics, vaccines, and diagnostics tailored to the continent.
From Sample
to Insight
Blood, serum, and tissue samples collected from clinical cohorts, vaccine trial participants, and community surveillance programmes.
Flow cytometry, ELISA, neutralisation assays, and multiplex cytokine profiling to characterise immune responses in detail.
Deep phenotyping of immune cell subsets and transcriptomic profiling to understand mechanistic drivers of protection or disease.
Integrating immunological findings with genomic, clinical, and epidemiological data for comprehensive disease understanding.
Translating findings into diagnostic tools, therapeutic targets, vaccine candidates, and evidence-based clinical guidelines.
Diseases &
Immune Studies
Research &
Partner Network
Integrating genomic sequencing with immunological profiling to link pathogen variants with host immune outcomes.
Running flow cytometry, serology, and immunological assays to support research across all disease areas.
Collaborating with hospitals and clinical networks to access patient cohorts and translate findings into clinical practice.
Contributing immunological data to international vaccine evaluation consortia including WHO, IAVI, and HVTN.
Meet the
Team
